Microparticles produced by the hydrogel template method for sustained drug delivery

Acharya, 2010, The hydrogel template method for fabrication of homogeneous nano/microparticles, J. Control. Release, 141, 314, 10.1016/j.jconrel.2009.09.032 Acharya, 2010, A study of drug release from homogeneous PLGA microstructures, J. Control. Release, 146, 201, 10.1016/j.jconrel.2010.03.024 Amann, 2010, In vitro–in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia, Pharm. Res., 27, 1730, 10.1007/s11095-010-0152-4 Berkland, 2003, PLG microsphere size controls drug release rate through several competing factors, Pharm. Res., 20, 1055, 10.1023/A:1024466407849 Berkland, 2004, Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres, J. Control. Release, 94, 129, 10.1016/j.jconrel.2003.09.011 Bodmeier, 1988, Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method, Int. J. Pharm., 43, 179, 10.1016/0378-5173(88)90073-7 Cho, 2000, Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin, Arch. Pharmacal. Res., 23, 385, 10.1007/BF02975452 da Silva, 2009, Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone, Int. J. Pharm., 368, 45, 10.1016/j.ijpharm.2008.09.054 Decuzzi, 2010, Size and shape effects in the biodistribution of intravascularly injected particles, J. Control. Release, 141, 320, 10.1016/j.jconrel.2009.10.014 Doan, 2011, Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery, Int. J. Pharm., 414, 112, 10.1016/j.ijpharm.2011.05.007 Engineer, 2011, Effect of copolymer ratio on hydrolytic degradation of poly(lactide-co-glycolide) from drug eluting coronary stents, Chem. Eng. Res. Des., 89, 328, 10.1016/j.cherd.2010.06.013 Gaspar, 1998, Formulation of l-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release, J. Control. Release, 52, 53, 10.1016/S0168-3659(97)00196-X Gaumet, 2009, Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size, Eur. J. Pharm. Sci., 36, 465, 10.1016/j.ejps.2008.11.015 Gorr, 2012, Characteristic size for onset of coffee-ring effect in evaporating lysozyme-water solution droplets, J. Phys. Chem. B, 116, 12213, 10.1021/jp307933a Hong, 2012, In vitro degradation and drug-release behavior of electrospun, fibrous webs of poly(lactic-co-glycolic acid), J. Appl. Polym. Sci., 124, 209, 10.1002/app.33357 Hora, 1990, Release of human serum-albumin from poly(lactide-co-glycolide) microspheres, Pharm. Res., 7, 1190, 10.1023/A:1015948829632 Huang, 2012, Investigation of a-PVA/s-PVA hydrogels prepared by freezing–thawing method, Fibers Polym., 13, 955, 10.1007/s12221-012-0955-5 Huang, 2001, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control. Release, 73, 121, 10.1016/S0168-3659(01)00248-6 Kang, 2009, A drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine (DPCPX), Mol. Pharm., 6, 1110, 10.1021/mp8002623 Kauffman, 2012, Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression, Int. J. Pharm., 422, 356, 10.1016/j.ijpharm.2011.10.034 Le Ray, 2003, Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation, Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility, Biomaterials, 24, 443, 10.1016/S0142-9612(02)00357-5 Lee, 2010, Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery, J. Control. Release, 146, 61, 10.1016/j.jconrel.2010.05.026 Lee, 2012, Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system, Int. J. Pharm., 427, 305, 10.1016/j.ijpharm.2012.02.011 Li, 2008, Effects of polymer degradation on drug release from PLGA-mPEG microparticles: a dynamic study of microparticle morphological and physicochemical properties, J. Appl. Polym. Sci., 108, 2458, 10.1002/app.27823 Maa, 2000, Biopharmaceutical powders particle formation and formulation considerations, Curr. Pharm. Biotechnol., 1, 283, 10.2174/1389201003378898 Matsumoto, 2005, Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide), J. Control. Release, 106, 172, 10.1016/j.jconrel.2005.03.026 Mohamed, 2008, Engineering biodegradable polyester particles with specific drug targeting and drug release properties, J. Pharm. Sci., 97, 71, 10.1002/jps.21082 Ohagan, 1994, The preparation and characterization of poly(lactide-co-glycolide) microparticles. 3. microparticle/polymer degradation rates and the in-vitro release of a model protein, Int. J. Pharm., 103, 37, 10.1016/0378-5173(94)90201-1 Okuzono, 2009, Final shape of a drying thin film, Phys. Rev. E, 80, 10.1103/PhysRevE.80.021603 Ozalp, 2001, Controlled release of vancomycin from biodegradable microcapsules, J. Microencapsul., 18, 89, 10.1080/026520401750038638 Sah, 1997, Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres, J. Control. Release, 47, 233, 10.1016/S0168-3659(97)01647-7 Schenderlein, 2004, Partial solubility parameters of poly(d,l-lactide-co-glycolide), Int. J. Pharm., 286, 19, 10.1016/j.ijpharm.2004.07.034 Siepmann, 2004, Effect of the size of biodegradable microparticles on drug release: experiment and theory, J. Control. Release, 96, 123, 10.1016/j.jconrel.2004.01.011 Sinclair, 2011, Physical stability and recrystallization kinetics of amorphous ibipinabant drug product by Fourier transform raman spectroscopy, J. Pharm. Sci., 100, 4687, 10.1002/jps.22658 Su, 2011, Biodegradable poly(d,l-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: zero-order release formulation, Pharm. Dev. Technol., 16, 377, 10.3109/10837451003739297 Thomas, 2010, Particle size influences the immune response produced by hepatitis b vaccine formulated in inhalable particles, Pharm. Res., 27, 905, 10.1007/s11095-010-0094-x Tran, 2011, Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?, Int. J. Pharm., 407, 1, 10.1016/j.ijpharm.2011.01.027 Tran, 2011, Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?, Int. J. Pharm., 407, 1, 10.1016/j.ijpharm.2011.01.027 Vay, 2012, A detailed view of microparticle formation by in-process monitoring of the glass transition temperature, Eur. J. Pharm. Biopharm., 81, 399, 10.1016/j.ejpb.2012.02.019 Wei, 2012, A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles, Mol. Pharm., 9, 2039, 10.1021/mp300126t Wischke, 2008, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, Int. J. Pharm., 364, 298, 10.1016/j.ijpharm.2008.04.042 Yang, 2001, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method, Biomaterials, 22, 231, 10.1016/S0142-9612(00)00178-2 Yeo, 2004, Control of encapsulation efficiency and initial burst in polymeric microparticle systems, Arch. Pharmacal. Res., 27, 1, 10.1007/BF02980037